Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.94 - $1.94 $255,022 - $526,322
271,300 Added 685.1%
310,900 $5,000
Q4 2021

Feb 14, 2022

SELL
$2.58 - $3.91 $484,008 - $733,516
-187,600 Reduced 82.57%
39,600 $1,000
Q3 2021

Nov 15, 2021

SELL
$2.77 - $4.05 $160,106 - $234,090
-57,800 Reduced 20.28%
227,200 $45,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $131,841 - $319,194
77,100 Added 37.09%
285,000 $141,000
Q1 2021

May 17, 2021

BUY
$0.85 - $5.27 $176,715 - $1.1 Million
207,900 New
207,900 $37,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $610M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.